4-methoxyamphetamine has been researched along with ticagrelor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgartner, I; Berger, JS; Blomster, J; Fowkes, FGR; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Mulder, H; Norgren, L; Olivier, CB; Patel, MR; Rockhold, FW | 1 |
| Åkerblom, A; Aukrust, P; Becker, RC; Gregersen, I; Halvorsen, B; Himmelmann, A; James, SK; Johansen, HT; Kontny, F; Lakic, TG; Lindbäck, J; Lunde, NN; Michelsen, AE; Ryeng Skagen, K; Siegbahn, A; Skjelland, M; Solberg, R; Storey, RF; Ueland, T; Wallentin, L | 1 |
2 trial(s) available for 4-methoxyamphetamine and ticagrelor
| Article | Year |
|---|---|
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
Topics: Aged; Ankle Brachial Index; Clopidogrel; Coronary Artery Bypass; Death; Extremities; Female; Hospitalization; Humans; Incidence; Ischemia; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor | 2019 |
Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
Topics: Acute Coronary Syndrome; Aged; Atherosclerosis; Case-Control Studies; Clopidogrel; Cysteine Endopeptidases; Cysteine Proteases; Death; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticagrelor; Treatment Outcome | 2020 |